NCT07084857

Brief Summary

bone density and muscle strength appear to be more related to each other. Examining the association between muscle strength and bone health is very important in recognizing risk factors for lower extremity muscle weakness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

May 20, 2025

Last Update Submit

April 2, 2026

Conditions

Keywords

OsteoporosisBone Mineral DensityIsokinetic Strength;Hip MusclesKnee Muscles

Outcome Measures

Primary Outcomes (2)

  • isokinetic strength of hip muscles

    isokinetic hip muscle stregth will be measured using Biodex system 3 Isokinetic Dynamometer

    one month

  • Bone mineral density

    bone mineral density measured by dual energy x ray absorptiometry scan

    one month

Secondary Outcomes (1)

  • isokinetic strength of knee muscles

    one month

Interventions

correlational analysis between BMD and isokinetic lower extremity strength

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Based on a sample size calculation via G Power software, a total of 70 participants will be required to participate in the study taking in consideration 20% drop out. A total 66 elderly women with ages range from 50 to 70 years will be involved in the study

You may qualify if:

  • The group of OP (n=33) has femoral BMD T-scores below -2.5 diagnosed by DEXA scan according to the WHO \[8\] classification of BMD in 2003,
  • The control group has normal BMD T-scores more than -1.

You may not qualify if:

  • There was any neurological, musculoskeletal, rheumatologic, respiratory or cardiovascular problem.
  • They were receiving medications that result in bone loss such as corticosteroids,
  • They had vertigo, dizziness, or any vestibular problem,
  • They had hyperthyroidism or hyperparathyroidism. 6- They actively participate in sports activities,
  • They underwent previous surgery (e.g; joint replacement) or history of fractures of the lower extremity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azza Mohammed

Giza, 12511, Egypt

Location

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Azza M Abdelmohsen, professor

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr

Study Record Dates

First Submitted

May 20, 2025

First Posted

July 25, 2025

Study Start

February 8, 2025

Primary Completion

March 28, 2025

Study Completion

March 29, 2025

Last Updated

April 8, 2026

Record last verified: 2026-04

Locations